Erodible Polymer Particle Oral Vaccine Adjuvant

Technology Description

Heliobacter pylori is a known cause of gastric cancer, and over half of the world’s population is infected with H. pylori. According to the World Health Organization, gastric cancer caused by H. pylori is the third leading cause of cancer mortality in the world. A novel nanoparticle adjuvant preparation has been developed which combines vaccination with an agent that enhances gastric inflammation, boosts immunity and improves clearance of the H. pylori. This novel strategy has been tested in vitro and in vivo (mouse studies).

Intellectual Property Info

A provisional patent application has been filed.

Patent Status